🇺🇸 FDA
Pipeline program

0.9% sodium chloride aqueous solution for IV infusion

CLI-10067AA1-02

Phase 2 small_molecule active

Quick answer

0.9% sodium chloride aqueous solution for IV infusion for Idiopathic pulmonary fibrosis (IPF) is a Phase 2 program (small_molecule) at Chiesi Farmaceutici S.p.A with 1 ClinicalTrials.gov record(s).

Program details

Company
Chiesi Farmaceutici S.p.A
Indication
Idiopathic pulmonary fibrosis (IPF)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials